Health Care: Drugs

Bristol-Myers Squibb Company (BMY: NYSE)

$56.05 0.38 | 0.68%
04/28/17 - 04:01 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 19.43B 16.56B 15.88B 16.39B
Cost of Sales 4.56B 3.53B 3.46B 3.86B
Gross Operating Profit 14.86B 13.03B 12.41B 12.53B
Selling, General, and Administrative Expenses 4.91B 4.84B 4.82B 4.94B
Research & Development 4.94B 5.92B 4.53B 3.73B
Operating Income before D & A (EBITDA) 5.01B 2.27B 3.06B 3.86B
Depreciation & Amortization 382.00M 376.00M 467.00M 763.00M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 1.42B 288.00M -114.00M -6.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 6.08B 2.26B 2.58B 3.09B
Interest Expense 167.00M 184.00M 203.00M 199.00M
Pre-Tax Income 5.92B 2.08B 2.38B 2.89B
Income Taxes 1.41B 446.00M 352.00M 311.00M
Minority Interest 50.00M 66.00M 25.00M 17.00M
Net Income From Continuing Operations 4.51B 1.63B 2.03B 2.58B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.51B 1.63B 2.03B 2.58B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.46B 1.56B 2.00B 2.56B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.51B 1.63B 2.03B 2.58B
Preferred Dividends
Net Income Available To Common 4.51B 1.63B 2.03B 2.58B
Basic EPS from Continuing Ops. 2.67 0.94 1.21 1.56
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.67 0.94 1.21 1.56
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.67 0.94 1.21 1.56
Basic Normalized Net Income/Share 2.67 0.94 1.21 1.56
EPS fr Continuing Ops. 2.65 0.93 1.20 1.54
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.65 0.93 1.20 1.54
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.65 0.93 1.20 1.54
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.65 0.93 1.20 1.54
Dividends Paid per Share 1.14 1.49 1.45 1.76

Portfolios with BMY

Latest BMY Headlines from TheStreet

More Financial News for BMY

Press Releases for BMY

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter